Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dinulescu

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Cell|September 13, 2011
Lung cancer signatures in plasma based on proteome profiling of mouse tumor modelsAyumu Taguchi, Katerina Politi, Sharon J Pitteri, et al.
Cancers|August 26, 2023
Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor CellsThomas J Gerton, Allen Green, Marco Campisi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapyShannon M McAuliffe, Stefanie L Morgan, Gregory A Wyant, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2017
Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian CancerDouglass W Tucker, Christopher R Getchell, Eric T McCarthy, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Cell Reports. Medicine|September 16, 2023
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoringSyeda Maheen Batool, Anudeep Yekula, Prerna Khanna, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Cell|September 13, 2011
Lung cancer signatures in plasma based on proteome profiling of mouse tumor modelsAyumu Taguchi, Katerina Politi, Sharon J Pitteri, et al.
Cancers|August 26, 2023
Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor CellsThomas J Gerton, Allen Green, Marco Campisi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2012
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapyShannon M McAuliffe, Stefanie L Morgan, Gregory A Wyant, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2017
Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian CancerDouglass W Tucker, Christopher R Getchell, Eric T McCarthy, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Cell Reports. Medicine|September 16, 2023
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoringSyeda Maheen Batool, Anudeep Yekula, Prerna Khanna, et al.
Pageof 6